krusei ATCC 6258 and a fluconazole-resistant Candida albicans were used for quality control.
The effect of supplemental 2%G on RPMI-MOPS and AM3 after various incubation periods is shown in Table 1 . Addition of 2%G to either RPMI-MOPS or AM3 had little effect on the observed MICs. Similarly, the length of incubation did not significantly influence the geometric mean MICs. After 48 h of incubation, MIC values were one-to two-fold higher than the 24 h values. Caspofungin, however, appears to be more potent in AM3, with geometric mean MICs fourto seven-fold lower in AM3 than in RPMI-MOPS. Test conditions have been found to have significant effects on the activity in vitro of azole and triazole antifungals. 2 However, with the candin antifungals, the impact of test conditions is unclear. Krishnarao & Galgiani 3 recently analysed the test conditions on the activities in vitro of caspofungin and LY303366 against yeast isolates and failed to identify any significant impact. In contrast, several authors showed that echinocandins LY303366 and cilofungin appear to be considerably more potent against yeasts when tested in AM3 compared with RPMI-MOPS. 4, 5 In the present study, we have made similar observations, with caspofungin showing an increased activity in AM3 when compared with RPMI-MOPS. However, the discrepancies between study results might have been caused by the testing systems used in the different studies; like Pfaller et al., 4 we used a broth microdilution system, whereas in their study, Krishnarao & Galgiani 3 used a broth macrodilution system.
The lack of influence of glucose supplementation on the anti-Candida activity of caspofungin observed in our study was surprising. Glucose supplementation has been shown to prolong the exponential growth cycle and promote denser growth rates of Candida species. 6 As a consequence, glucose supplementation of test medium has been proposed to facilitate and accelerate endpoint determinations after 24 h of incubation with fungistatic azoles. In our study, ambiguous endpoint determinations after 24 h of incubation were encountered on several occasions and were largely observed with C. parapsilosis. The intrinsic lower growth rate of this particular Candida species, which remains unaffected by glucose supplementation, was likely to be responsible for those ambiguous readings in our study. 6 The neutral impact on the activity of caspofungin against the other Candida species tested in our study, despite presumably denser growth rates in glucose-supplemented medium, may be attributable to the rapid fungicidal activity of caspofungin against actively growing yeasts.
In conclusion, AM3 appears to increase the activity in vitro of caspofungin against clinical Candida isolates. Addition of 2%G to either RPMI-MOPS or AM3 had little impact on the observed MICs, and in general the MICs observed after 48 h of incubation did not vary from those obtained after 24 h of incubation. 
